{"schema_version":"secwatch.filing_event.v1","accession":"0001370053-25-000055","form_type":"8-K","ticker":"ANAB","cik":"0001370053","company_name":"ANAPTYSBIO, INC","filed_at":"2025-06-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.083601+00:00","generated_at":"2026-05-19T04:27:52.010745+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.15,"confidence":"high","headline":"AnaptysBio shareholders approve amended equity plan, elect directors at 2025 annual meeting","bullets":["Elected Rita Jain, John Orwin, and J. Anthony Ware as Class II directors for three-year terms with over 21M votes for each.","Approved amendment to 2017 Equity Incentive Plan with 18.0M for, 6.4M against; increases share reserve to 13.5M shares.","Ratified KPMG as independent auditor for FY2025 with 27.2M votes for, 17K against.","Advisory say-on-pay passed with 17.8M for, 6.6M against; shareholders preferred one-year frequency for future votes."],"urls":{"canonical":"https://secwatch.observer/filing/0001370053-25-000055","json":"https://secwatch.observer/filing/0001370053-25-000055.json","markdown":"https://secwatch.observer/filing/0001370053-25-000055.md","text":"https://secwatch.observer/filing/0001370053-25-000055.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1370053/000137005325000055/0001370053-25-000055-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1370053/000137005325000055/anab-20250617.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T04:27:52.010745+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}